V Foulon
Overview
Explore the profile of V Foulon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vandael E, De WuLf I, Foulon V
J Pharm Belg
. 2018 Oct;
(4):14-23.
PMID: 30281244
Introduction Community pharmacists have an important role in the management of drug-drug interactions (DD). One of the interactions that can lead to serious adverse drug events, more specifically Torsade de...
2.
[Frequency and nature of drug related problems with corticosteroids in Belgian community pharmacies]
Lelubre M, Koubaity M, De WuLf I, Boussery K, De Meyer G, Foulon V, et al.
J Pharm Belg
. 2018 Oct;
(3):32-41.
PMID: 30281242
Aim Aims are: 1] Identify causes of Drug Related Problems (DRPs), interventions performed by pharmacists and results of corticosteroid- related problems and 2] distinguish between problems related to inhaled and...
3.
Wuyts J, Maesschalck J, De WuLf I, Foubert K, Boussery K, De Lepeleire J, et al.
BMC Health Serv Res
. 2018 Aug;
18(1):623.
PMID: 30089523
Background: Aged polymedicated patients are particularly vulnerable for drug-related problems. A medication review aims to optimize the medication use of patients and improve health outcomes. In this study, the effect...
4.
Geeraerts A, Dilles T, Foulon V, Habraken H, Petrovic M, Strauven G, et al.
Tijdschr Gerontol Geriatr
. 2017 Sep;
48(5):195-202.
PMID: 28884457
Psychotropic drugs (hypno-sedatives, antidepressants and antipsychotics) are commonly used in the older population. On the long term, psychotropic drug use in older persons is associated with several negative functional outcomes...
5.
Huysmans K, De WuLf I, Foulon V, De Loof H, Steurbaut S, Boussery K, et al.
J Pharm Belg
. 2014 May;
(1):4-15.
PMID: 24804389
Introduction: The identification, the management and if possible the prevention of drug related problems (DRP), are the main responsibilities of pharmacists. Aim: The aims of the study were 1/to investigate...
6.
Liekens S, Hulshagen L, Dethier M, Laekeman G, Foulon V
J Pharm Belg
. 2014 Jan;
(4):18-27.
PMID: 24449969
Medication adherence in chronic conditions such as asthma, type 2 diabetes, heart failure, HIV and cancer appears to be a frequent problem. However, the literature on adherence in patients who...
7.
Van de Putte M, Appels S, Boone T, Collienne S, Daems T, De Lepeleire J, et al.
J Pharm Belg
. 2013 May;
(3):24-9.
PMID: 23697093
Medication management in home care is an error prone process. In a small pilot project in Flanders, community pharmacists collaborated with physicians and home care nurses through a shared electronic...
8.
Foulon V, Schoffski P, Wolter P
Acta Clin Belg
. 2011 Jun;
66(2):85-96.
PMID: 21630604
The steady increase in the use of oral anticancer drugs in modern oncology has created a paradigm shift, challenging traditional attitudes towards cancer care and requiring new concepts of organization...
9.
Liekens S, Smits T, Laekeman G, Foulon V
Eur Psychiatry
. 2011 Mar;
27(7):528-35.
PMID: 21392945
Objective: The aim of the present study was to measure stigma among community pharmacists regarding patients with depression, using social distance as a proxy measure. Furthermore, factors influencing stigmatization were...
10.
De WuLf I, Depuydt C, Develter M, De Waele L, Leyssens A, Pierreux T, et al.
J Pharm Belg
. 2011 Feb;
(4):110-7.
PMID: 21294317
No abstract available.